Compile Data Set for Download or QSAR
Report error Found 106 Enz. Inhib. hit(s) with all data for entry = 7734
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213357(US9278968, 111)
Affinity DataEC50:  560nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213250(US9278968, 9)
Affinity DataEC50:  720nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213243(US9278968, 3)
Affinity DataEC50:  720nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213360(US9278968, 114)
Affinity DataEC50:  730nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213253(US9278968, 12)
Affinity DataEC50:  780nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213254(US9278968, 13)
Affinity DataEC50:  840nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213364(US9278968, 118)
Affinity DataEC50:  1.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213252(US9278968, 11)
Affinity DataEC50:  1.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213321(US9278968, 77)
Affinity DataEC50:  1.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213244(US9278968, 4)
Affinity DataEC50:  1.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213336(US9278968, 92)
Affinity DataEC50:  1.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213335(US9278968, 91)
Affinity DataEC50:  1.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213351(US9278968, 107a)
Affinity DataEC50:  1.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213259(US9278968, 18)
Affinity DataEC50:  1.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213246(US9278968, 6)
Affinity DataEC50:  1.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213294(US9278968, 53)
Affinity DataEC50:  1.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213300(US9278968, 59)
Affinity DataEC50:  1.90E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213296(US9278968, 55)
Affinity DataEC50:  2.00E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213257(US9278968, 16)
Affinity DataEC50:  2.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213293(US9278968, 52)
Affinity DataEC50:  2.20E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213279(US9278968, 38)
Affinity DataEC50:  2.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213242(US9278968, 2)
Affinity DataEC50:  2.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213346(US9278968, 102)
Affinity DataEC50:  2.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213327(US9278968, 83)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213289(US9278968, 48)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213295(US9278968, 54)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213315(US9278968, 72)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213256(US9278968, 15)
Affinity DataEC50:  2.80E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213329(US9278968, 85)
Affinity DataEC50:  2.90E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213299(US9278968, 58)
Affinity DataEC50:  3.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213340(US9278968, 96)
Affinity DataEC50:  3.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213341(US9278968, 97)
Affinity DataEC50:  3.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213265(US9278968, 24)
Affinity DataEC50:  3.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213260(US9278968, 19)
Affinity DataEC50:  3.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213298(US9278968, 57)
Affinity DataEC50:  3.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213281(US9278968, 40)
Affinity DataEC50:  3.80E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213313(US9278968, 70)
Affinity DataEC50:  3.80E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213262(US9278968, 21)
Affinity DataEC50:  4.00E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213255(US9278968, 14)
Affinity DataEC50:  4.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213280(US9278968, 39)
Affinity DataEC50:  4.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213353(US9278968, 108a)
Affinity DataEC50:  4.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213311(US9278968, 69)
Affinity DataEC50:  4.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213272(US9278968, 31)
Affinity DataEC50:  4.90E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213322(US9278968, 78)
Affinity DataEC50:  5.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213282(US9278968, 41)
Affinity DataEC50:  5.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213332(US9278968, 88)
Affinity DataEC50:  5.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213363(US9278968, 117)
Affinity DataEC50:  5.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213241(US9278968, 1)
Affinity DataEC50:  5.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213271(US9278968, 30)
Affinity DataEC50:  5.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213330(US9278968, 86)
Affinity DataEC50:  5.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2017
Entry Details
US Patent

Displayed 1 to 50 (of 106 total ) | Next | Last >>
Jump to: